625 related articles for article (PubMed ID: 32176631)
1. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
[TBL] [Abstract][Full Text] [Related]
2. miR-1229-3p as a Prognostic Predictor Facilitates Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma.
Zhang C; Zhang Q; Li H; Wu Y
Horm Metab Res; 2021 Nov; 53(11):759-766. PubMed ID: 34740278
[TBL] [Abstract][Full Text] [Related]
3. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion.
Chen Z; Zhang Y
Mol Biotechnol; 2022 Jan; 64(1):33-41. PubMed ID: 34519997
[TBL] [Abstract][Full Text] [Related]
5. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
6. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
7. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
8. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
Su Y; Xie R; Xu Q
Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
13. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
[TBL] [Abstract][Full Text] [Related]
14. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
15. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.
Ying J; Yu X; Ma C; Zhang Y; Dong J
Mol Med Rep; 2017 Aug; 16(2):1603-1611. PubMed ID: 28627662
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
